science wire

« BACK

Pharmacology



Results 351 - 400 of 1869.
« Previous 1 ... 4 5 6 7 8 9 10 11 12 ... 38 Next »


Health - Pharmacology - 18.11.2019
College gets infectious at November's Imperial Lates
College gets infectious at November’s Imperial Lates
From disease roulette to infection-detecting dogs, November's Imperial Lates event explored infections, deadly diseases, and our work to beat them.

Pharmacology - Health - 18.11.2019
Roche to present new and updated data for seven approved and investigational medicines across multiple types of breast cancer at the 2019 San Antonio Breast Cancer Symposium
Study results reflect advancements in HER2-positive, triple-negative, and hormone receptor-positive breast cancer Follow-up data from pivotal phase III APHINITY study evaluating Perjeta plus Hercepti

Pharmacology - Health - 17.11.2019
Novartis PARAGON-HF analyses suggest Entresto benefit beyond HFrEF
Patients & Caregivers Healthcare Professionals Society & ESG Entresto (sacubitril/valsartan) demonstrated greatest benefit in HFpEF patients with ejection fractions adjacent to HFrEF, compare

Pharmacology - Health - 15.11.2019
New Novartis medicine Adakveo (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
Patients & Caregivers Healthcare Professionals Society & ESG Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications 1   Adakveo reduced the an

Pharmacology - Health - 15.11.2019
Novartis receives positive CHMP opinion for Mayzent (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS)
Patients & Caregivers Healthcare Professionals Society & ESG If approved, Mayzent (siponimod) will be the first and only oral treatment specifically indicated for patients with active seconda

Pharmacology - Health - 15.11.2019
CHMP recommends conditional EU approval of Roche’s Polivy for people with previously treated aggressive lymphoma
First-in-class antibody-drug conjugate that specifically targets CD79b, a protein expressed in the majority of B-cells Targeted off-the-shelf treatment represents potential new option for people with

Pharmacology - Health - 15.11.2019
CHMP recommends EU approval of Roche’s Kadcyla for the adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment
Kadcyla cut the risk of disease recurrence or death by half compared to Herceptin in the adjuvant setting for specific patients with HER2-positive early breast cancer At three years, 88.3% of

Health - Pharmacology - 14.11.2019
$20 million fundraising effort will support efforts to improve treatment for lung disease
UCLA Health has launched a $20 million fundraising initiative to create a new center for advanced lung disease at the David Geffen School of Medicine at UCLA.

Pharmacology - Health - 14.11.2019
U of M Expert: U.S. Antibiotic Awareness Week
U.S. Antibiotic Awareness Week , which raises awareness of the threat of antibiotic resistance and the importance of appropriate antibiotic use, is November 18-24, 2019. The Centers for

Pharmacology - Health - 12.11.2019
New Novartis PREVENT data show Cosentyx delivers early relief in axial spondyloarthritis
Patients & Caregivers Healthcare Professionals Society & ESG 42.2% of patients with non-radiographic axial spondyloarthritis (nr-axSpA) treated with Cosentyx had improved ASAS40 scores

Health - Pharmacology - 12.11.2019
Sandoz presents real-world data showing effectiveness of Erelzi (etanercept-szzs) in rheumatic disease treatment
Patients & Caregivers Healthcare Professionals Society & ESG Interim results from COMPACT, a multi-country, real-world study of Erelzi for approved rheumatic diseases presented at 2019 ACR/AR

Health - Pharmacology - 11.11.2019
Professor Jonathan Schott named ARUK’s first Chief Medical Officer
National dementia research charity Alzheimer's Research UK (ARUK) has appointed UCL Professor Jonathan Schott as the charity's first ever Chief Medical Officer (CMO).

Health - Pharmacology - 11.11.2019
£2.5 million EU grant to help save NHS patients fighting for life
A new multi-million pound EU-funded research project could help NHS staff provide life-saving treatment to some of the country's most ill patients.

Pharmacology - Health - 11.11.2019
Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone
NOBILITY phase II study showed 40% of patients treated with Gazyva plus standard of care achieved complete renal response at Week 76, compared to 18% of patients treated with placebo plus standard of

Pharmacology - Life Sciences - 11.11.2019
Roche’s risdiplam meets primary endpoint in pivotal SUNFISH trial in people with type 2 or 3 spinal muscular atrophy
Study demonstrated statistically significant improvements in the overall study population with Type 2 or 3 SMA No treatment related safety findings leading to withdrawal seen in any risdiplam trial t

Health - Pharmacology - 08.11.2019
Birmingham experts join Indian medics to counter surgical infection threat
University of Birmingham experts joined medical professionals in India to lead work in improving care for surgical patients.

Environment - Pharmacology - 08.11.2019
Saving Australia's sea lion population
Saving Australia’s sea lion population
Every sea lion pup in Australia contracts hookworm. Veterinary scientist Rachael Gray and her team are conducting a trial at Seal Bay, Kangaroo Island, with a topical treatment that could help the endangered species' population recover.

Health - Pharmacology - 07.11.2019
German Research Foundation approves new Clinical Research Group
German Research Foundation approves new Clinical Research Group
They are quiet - and in many cases fatal: systemic inflammatory reactions such as sepsis are the third most frequent cause of death in Germany.

Law - Pharmacology - 06.11.2019
Lessons from California’s vaccine exemption laws
California vaccine laws are among the toughest in the nation, particularly since the state did away with the  personal belief and religious exemption  in 2015 following a measles outbreak that began in Disneyland.

Health - Pharmacology - 04.11.2019

Health - Pharmacology - 04.11.2019
UofG scientists lead the way in next generation radiotherapy research
UofG scientists lead the way in next generation radiotherapy research
GLASGOW scientists have been awarded a major cash boost from Cancer Research UK to pioneer new radiotherapy technologies and techniques that could help more people survive cancer in the future.

Pharmacology - Health - 01.11.2019
Novartis Cosentyx shows encouraging results versus Humira * from first-of-its-kind head-to-head trial in psoriatic arthritis
Cosentyx narrowly missed statistical significance for superiority in ACR 20, the primary endpoint of the EXCEED trial, while showing numerically higher results versus Humira *   Statistically signifi

Health - Pharmacology - 01.11.2019
UQ antibody progresses to clinic with $20m investment
A potential therapy targeting difficult-to-treat immune system disorders such as rheumatoid arthritis will progress to clinical trials next year after securing $20 million in Series A funding.

Health - Pharmacology - 01.11.2019

Health - Pharmacology - 31.10.2019
National Cancer Institute awards UCLA prostate cancer program an $8.7 million grant
The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.

Health - Pharmacology - 30.10.2019
World’s largest study into the impact of arts on physical and mental health
The world's largest ever study into the impact and scalability of arts interventions on physical and mental health has been launched by UCL and King's College London, supported by a £2m award from Wellcome Trust.

Pharmacology - Life Sciences - 30.10.2019
Novartis announces AVXS-101 intrathecal study update
FDA placed a partial hold on AVXS-101 intrathecal clinical trials for SMA patients based on findings in a small pre-clinical animal study Adverse events that might be expected from the pre-clinical f

Pharmacology - Health - 30.10.2019
Roche’s marketing applications for satralizumab in neuromyelitis optica spectrum disorder accepted for review by EMA and FDA
Satralizumab represents a potential new approach to treating neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating disease often misdiagnosed as multiple sclerosis European Medicines A

Pharmacology - 28.10.2019
Wastewater monitoring gives insight into Australia's drug consumption
Wastewater monitoring gives insight into Australia’s drug consumption
Queensland has some of the highest fentanyl consumption and MDA excretion levels in the country, according to the latest report by The Australian Criminal Intelligence Commission (ACIC). The eighth report has been released on the same day as a new contract was signed between The University of Queensland and the ACIC for the delivery of The National Wastewater Drug Monitoring Program (NWDMP).

Health - Pharmacology - 28.10.2019

Pharmacology - 28.10.2019
Wastewater drug monitoring program provides insight into Australia's drug consumption
Wastewater drug monitoring program provides insight into Australia’s drug consumption
Queensland has some of the highest fentanyl consumption and MDA excretion levels in the country, according to the latest report by The Australian Criminal Intelligence Commission (ACIC). The eighth report has been released on the same day as a new contract was signed between The University of Queensland and the ACIC for the delivery of The National Wastewater Drug Monitoring Program (NWDMP).

Pharmacology - Health - 25.10.2019
UK and China scientists developing new drugs to fight Tuberculosis
University of Birmingham scientists have worked with partners in Guangzhou to develop new drugs that can tackle global health epidemics, which have an impact on China's rural communities. Researchers at the University of Birmingham joined forces with their counterparts at the Guangzhou Institutes of Biomedicine and Health (GIBH) to develop a promising hit for anti-Tuberculosis therapy and initiate a drug discovery effort.

Health - Pharmacology - 24.10.2019
UCL and GOSH welcome first patients to The Zayed Centre for Research into Rare Disease in Children
UCL and Great Ormond Street Hospital (GOSH) today celebrated the opening of The Zayed Centre for Research into Rare Disease in Children, by welcoming the first patients through its doors for treatment.

Environment - Pharmacology - 24.10.2019
Science tales
Three M.F.A. students from the UCLA School of Theater, Film and Television have been awarded Alfred P. Sloan Foundation Awards, which recognize scripts that demonstrate examples of real or plausible science.

Pharmacology - Health - 21.10.2019
Roche’s Tecentriq in combination with Avastin increased overall survival and progression-free survival in people with unresectable hepatocellular carcinoma
First Phase III cancer immunotherapy study to show an improvement in overall survival and progression-free survival for the treatment of the most common form of liver cancer Data will be submitted to

Health - Pharmacology - 18.10.2019
From fundamental research to new medications
From fundamental research to new medications
Four research teams from the Technical University of Munich (TUM) have received m4 Awards this year.

Health - Pharmacology - 18.10.2019
Roche announces FDA approval of Xofluza (baloxavir marboxil) for people at high risk of developing influenza-related complications
Single-dose Xofluza is the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from influenza (flu) The Centers for Disease Control

Pharmacology - Social Sciences - 17.10.2019
The Power of Song: Why your doctor should be prescribing choir practice
The Power of Song: Why your doctor should be prescribing choir practice
GPs should prescribe participation in communal singing activities to patients to raise self-esteem and overcome loneliness, a tuneful event at the University of Sussex was told this week. Dr Sarah Andersen, a practicing GP and former masters' student at the Brighton and Sussex Medical School , told the Singing for Wellbeing event held at the University of Sussex that academic studies indicated significant benefits if more doctors used community choirs as part of their social prescribing.
« Previous 1 ... 4 5 6 7 8 9 10 11 12 ... 38 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |